Effectiveness of anti-IgE and anti-IL-5 treatment in step 5 asthma patients.

被引：0
|
作者：
Saji, Junko [1 ]
Muraoka, Hiromi [1 ]
Nishimoto, Eriko [1 ]
Matsuzawa, Shin [2 ]
Okamoto, Mariko [2 ]
Inoue, Teppei [2 ]
Handa, Hiroshi [2 ]
Nishine, Hiroki [2 ]
Inoue, Takeo [2 ]
Miyazawa, Teruomi [2 ]
Mineshita, Masamichi [2 ]
机构：
[1] Kawasaki Municipal Tama Hosp, Div Resp Dis, Dept Internal Med, Kawasaki, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp Dis, Kawasaki, Kanagawa, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA1131
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1131
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-life effectiveness of anti-IL-5(-receptor) antibody treatment in patients with severe eosinophilic asthma
    Korn, Stephanie
    Ehrhard, Lucas
    Voigt, Stefanie
    Buhl, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [22] Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
    Burkill, S.
    Porsbjerg, C. M.
    Bourdin, A.
    Tran, T. N.
    Martin, N.
    Katial, R.
    Barker, P.
    Wechsler, M. E.
    Maspero, J.
    Bosnic-Anticevich, S.
    Chung, L. P.
    Katsoulotos, G.
    Christoff, G. C.
    Popov, T. A.
    Sadatsafavi, M.
    Torres-Duque, C. A.
    Ulrik, C.
    Assing, K. Dahl
    Hansen, S.
    Altraja, A.
    Lehtimaki, L. A.
    Papadopoulos, N. G.
    Kostikas, K.
    Salvi, S.
    Costello, R. W.
    Francesca, P.
    Iwanaga, T.
    Rhee, C. K.
    Al-Ahmad, M.
    Larenas-Linnemann, D.
    Fonseca, J. A.
    Amaral, R.
    Alving, K.
    Al-Lehebi, R.
    De-Llano, L. Perez
    Kirenga, B.
    Tsai, M.
    Mahboub, B.
    Pfeffer, P. E.
    Henley, W.
    Liu, Y.
    Lyu, J.
    Goh, C.
    Uthaman, T.
    Price, D.
    Townend, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] Anti-IL-5 therapy and the airway microbiome in asthma
    Sullivan, Ashley
    Ward, Chris
    Casey, Deborah
    Flynn, Deirdre
    Hunt, Eoin B.
    Eustace, Joseph A.
    O'Byrne, Paul M.
    Plant, Barry J.
    Macsharry, John A.
    Murphy, Desmond M.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [24] Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma
    Drick, Nora
    Brinkmann, Lina
    Fuge, Jan
    Welte, Tobias
    Suhling, Hendrik
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [25] Anti-IL-5 in the treatment of nasal polyps
    Kowalski, Marek L.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2007, 7 (03) : 195 - 196
  • [26] Anti-IgE antibodies for the treatment of asthma
    Buhl, R
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (01) : 27 - 34
  • [27] Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
    Bakakos, Agamemnon
    Rovina, Nikoleta
    Bakakos, Petros
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [28] Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial
    Valery, Solene
    Simon-Tillaux, Noemie
    Devouassoux, Gilles
    Bonniaud, Philippe
    Beurnier, Antoine
    Boudjemaa, Amel
    Chenivesse, Cecile
    Bourdin, Arnaud
    Gauquelin, Lisa
    Guillo, Sylvie
    Taille, Camille
    Estellat, Candice
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (04) : 922 - 932
  • [29] Combination anti-IgE and anti-IL5 therapies in patients with severe persistent asthma and allergic bronchopulmonary aspergillosis (ABPA)
    Patel, Jay
    Ayars, Andrew G.
    Rampur, Lahari
    Bronson, Stephen
    Altman, Matthew C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB234 - AB234
  • [30] Prevalence of Patients Eligible for Anti-IL-5 Treatment in a Cohort of Adult-Onset Asthma
    Ilmarinen, Pinja
    Tuomisto, Leena E.
    Niemela, Onni
    Kankaanranta, Hannu
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (01): : 165 - +
12345